Labcorp Launches Labcorp® Plasma Detect™ Extending Leadership into Molecular Residual Disease (MRD) Clinical Research

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of Labcorp® Plasma Detect™, the first clinically validated, tumor-informed, whole-genome sequencing circulating tumor DNA (ctDNA) molecular residual disease (MRD) solution in early stage colon cancer ...

Related Keywords

United States ,Netherlands ,American ,Christin Odonnell ,Kimbrel Arculeo ,Remond Fijneman ,Shakti Ramkissoon ,Netherlands Cancer Institute ,American Association For Cancer Research ,Genome Diagnostics Inc ,Labcorp Plasma Detect ,Plasma Detect ,Plasma Focus ,Plasma Complete ,Personal Genome Diagnostics ,American Association ,Cancer Research ,Christino Donnell ,